Human Plasma with CPD

<strong>Human Plasma with CPD</strong>_x000D_ <strong>Catalog number:</strong> B2011329_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> CPD Human Plasma Proteins_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Smak Gregoor PJ, Harvey MS, Briët E, Brand A. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days Transfusion. 1993 Sep;33(9):735-8._x000D_ 2: Loh GOK, Wong EYL, Tan YTF, Ong LM, Ng RS, Wee HC, Peh KK. Simple and fast LC-MS/MS method for quantification of terazosin in human plasma and application to bioequivalence study J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jan 15;1163:122517._x000D_ 3: Vecchiarelli S, Passiglia F, D'Incecco A, Gallo M, De Luca A, Rossi E, D'Incà F, Minuti G, Landi L, Bennati C, Spreafico M, D'Arcangelo M, Mazza V, Normanno N, Cappuzzo F. Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC) Oncotarget. 2018 Apr 3;9(25):17554-17563._x000D_ 4: Skidgel RA, Erdös EG. Cellular carboxypeptidases Immunol Rev. 1998 Feb;161:129-41._x000D_ 5: Elsebaei F, Zhu Y. Fast gradient high performance liquid chromatography method with UV detection for simultaneous determination of seven angiotensin converting enzyme inhibitors together with hydrochlorothiazide in pharmaceutical dosage forms and spiked human plasma and urine Talanta. 2011 Jul 15;85(1):123-9._x000D_ 6: Lang-Meli J, Fuchs J, Mathé P, Ho HE, Kern L, Jaki L, Rusignuolo G, Mertins S, Somogyi V, Neumann-Haefelin C, Trinkmann F, Müller M, Thimme R, Umhau M, Quinti I, Wagner D, Panning M, Cunningham-Rundles C, Laubner K, Warnatz K. Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency J Clin Immunol. 2022 Feb;42(2):253-265._x000D_ 7: Chieregato K, Castegnaro S, Madeo D, Astori G, Pegoraro M, Rodeghiero F. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue Cytotherapy. 2011 Sep;13(8):933-43._x000D_ 8: Tzamaloukas AH, Raj DS, Onime A, Servilla KS, Vanderjagt DJ, Murata GH. The prescription of peritoneal dialysis Semin Dial. 2008 May-Jun;21(3):250-7._x000D_ 9: Oncken C, Mead EL, Dornelas EA, Kuo CL, Sankey HZ, Kranzler HR, Thurlow S. Opioid Use and Rate of Nicotine Metabolism Among Pregnant Smokers Nicotine Tob Res. 2020 May 26;22(6):1046-1050._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26347231">10: Oshita M, Yokoyama T, Takei Y, Takeuchi A, Ironside JW, Kitamoto T, Morita M. Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin Transfusion. 2016 Jan;56(1):223-30. </a>_x000D_ _x000D_ <strong>Products Related to Human Plasma with CPD can be found at</strong> <a href="https://moleculardepot.com/product-category/serum-plasma/"> Serum &amp; Plasma</a>